Modeling of drug release from erodible tablets

Journal of Pharmaceutical Sciences
I KatzhendlerM Friedman

Abstract

A general mathematical model was developed to describe drug release from erodible tablets undergoing surface erosion. The model (which is based on the Hopfenberg equation) takes into account the three dimensions of a tablet dosage form. The model enables the characterization of the release kinetics by one or two erosion rate constants depending on the hydrodynamic conditions of the system. The model can be used to compare the release rates of the drug within different batches produced under different conditions. The model was utilized to evaluate some factors affecting the release rate from erodible tablets consisting of hydroxypropyl methylcellulose and amoxicillin. The release data of amoxicillin measured from the whole tablet followed the equation developed. Amoxicillin release data measured from the planar surface of the tablet appeared to follow zero-order kinetics as predicted by theory for drug release from an erodible device maintaining constant surface area with time.

References

Sep 1, 1975·The Journal of Pharmacy and Pharmacology·M Donbrow, M Friedman
Jan 1, 1975·Journal of Pharmaceutical Sciences·M Donbrow, M Friedman
Aug 1, 1968·Journal of Pharmaceutical Sciences·H Lapidus, N G Lordi
Aug 1, 1995·Journal of Pharmaceutical Sciences·P ColomboN A Peppas
Oct 1, 1994·Pharmaceutical Research·A T Pham, P I Lee
Jan 1, 1958·Journal of the American Pharmaceutical Association·G LEVY, T W SCHWARZ

❮ Previous
Next ❯

Citations

May 25, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Wenjin CaoFeroz Jameel
Mar 11, 2004·International Journal of Pharmaceutics·Manuel Tapia-Albarran, Leopoldo Villafuerte-Robles
Aug 7, 2013·International Journal of Pharmaceutics·Chintan VoraRajashree Mashru
Apr 25, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·T Dürig, R Fassihi
May 29, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·I KatzhendlerM Friedman1
Sep 19, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·A HoffmanM Friedman
Sep 19, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·I KatzhendlerM Friedman
Sep 1, 2000·International Journal of Pharmaceutics·D L Munday, P J Cox
Jun 9, 2001·International Journal of Pharmaceutics·P KortesuoM Marvola
Apr 12, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·P Costa, J M Sousa Lobo
Jul 5, 2001·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·S TakkaA Sakr
Mar 8, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·H Y KarasuluT Köse
May 14, 1999·Pharmaceutical Science & Technology Today·R GandhiR Panchagnula
Apr 1, 2010·Journal of Pharmacy & Bioallied Sciences·Hitesh Chavda, Chhaganbhai Patel
May 31, 2014·BioMed Research International·Jieyu ZuoRaimar Löbenberg
Sep 7, 2006·Drug Development and Industrial Pharmacy·E Cedillo-RamírezA Hernández-León
Feb 28, 2008·Drug Development and Industrial Pharmacy·Pablo Emilio Gutiérrez-SánchezLeopoldo Villafuerte-Robles
Feb 12, 2005·Drug Development and Industrial Pharmacy·Jason T McConvilleHoward N E Stevens
Sep 23, 2003·Journal of Pharmaceutical Sciences·Mingping ZhangChi-Hwa Wang
Dec 18, 2013·Journal of Pharmaceutical Sciences·Eneko LarrañetaJosé Ramón Isasi
Aug 16, 2015·International Journal of Pharmaceutics·Pseidy Luz MamaniMaría Dolores Veiga
Jul 15, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Raphael PausYuanhui Ji
Mar 19, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chandrashekar RamanDaniel W Pack
Apr 15, 2004·International Journal of Pharmaceutics·Kwangwoo NamKazuhiko Ishihara
Nov 4, 2006·Advanced Drug Delivery Reviews·Chien-Chi Lin, Andrew T Metters
Apr 19, 2007·Journal of Microencapsulation·Chistopher R YoungJames W McGinity
Aug 23, 2019·Drug Development and Industrial Pharmacy·Irisappan SarathchandiranNandakumar Selvasudha
May 16, 2019·The British Journal of Radiology·Francis Boateng, Wilfred Ngwa
Feb 7, 2013·Chemical & Pharmaceutical Bulletin·Jung-Myung HaEun-Seok Park

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
H Y KarasuluT Köse
© 2022 Meta ULC. All rights reserved